Drug intelligence / Profile preview

cefotaxime + cefuroxime + gentamicin + prednisolone

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intravenous, Intramuscular, Oral (for Prednisolone)
01

Overview

This is a combination of three antibiotics—cefotaxime, cefuroxime, and gentamicin—with the corticosteroid prednisolone. - Cefotaxime is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death. It has broad-spectrum activity against Gram-positive and Gram-negative bacteria[2]. - Cefuroxime is a second-generation cephalosporin antibiotic with broad-spectrum activity against both Gram-positive and Gram-negative organisms; it also acts by inhibiting bacterial cell wall synthesis[4]. - Gentamicin is an aminoglycoside antibiotic that binds to the 30S subunit of bacterial ribosomes, inhibiting protein synthesis and causing misreading of mRNA, which results in bactericidal effects. - Prednisolone is a synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties; it acts primarily through glucocorticoid receptor agonism to modulate gene expression involved in inflammation. This combination may be used in clinical settings where both potent antibacterial coverage (including for severe or mixed infections) and anti-inflammatory action are required (e.g., certain ophthalmic surgeries or severe infections). The compatibility of such combinations must be carefully considered due to potential drug interactions or aggregate formation[1][3].

02

Targets

GR (Glucocorticoid receptor)PBP (Penicillin-binding protein family)Bacterial Ribosome

Beyond the preview

Go deeper on cefotaxime + cefuroxime + gentamicin + prednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefotaxime + cefuroxime + gentamicin + prednisolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call